› 6lvm

X-ray diffraction
2.53Å resolution

Crystal structure of FGFR3 in complex with pyrimidine derivative

Released:
DOI: 10.2210/pdb6lvm/pdb
PDB entry 6lvm coloured by chain, front view.
PDB entry 6lvm coloured by chain, side view.
PDB entry 6lvm coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2.
Kuriwaki I, Kameda M, Hisamichi H, Kikuchi S, Iikubo K, Kawamoto Y, Moritomo H, Kondoh Y, Amano Y, Tateishi Y, Echizen Y, Iwai Y, Noda A, Tomiyama H, Suzuki T, Hirano M
Bioorg Med Chem 28 115453 (2020)
PMID: 32278710

Function and Biology Details

Reaction catalysed: 
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-149677 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Fibroblast growth factor receptor 3 Chain: A
Molecule details ›
Chain: A
Length: 313 amino acids
Theoretical weight: 35.66 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: P22607 (Residues: 472-759; Coverage: 37%)
Gene names: FGFR3, JTK4
Sequence domains: Protein tyrosine and serine/threonine kinase

Ligands and Environments

1 bound ligand:
Ligand EVR 1 x EVR
1 modified residue:
Ligand PTR 3 x PTR

Experiments and Validation Details

Entry percentile scores
X-ray source: PHOTON FACTORY BEAMLINE AR-NE3A
Spacegroup: P21
Unit cell:
a: 48.143Å b: 61.225Å c: 59.645Å
α: 90° β: 112.98° γ: 90°
R-values:
R R work R free
0.211 0.207 0.279
Expression system: Escherichia coli

Quick links

Citations

1 review citation

Computational anti-COVID-19 drug design: progress and challenges.
Wang et al. (2022)
1 other article

3 mentions without citation

Machine learning assessment of the binding region as a tool for more efficient computational receptor-ligand docking.
Simončič et al. (2022)
2 more